Furosemide

(Mfr: SAA)(Conc: 2.9 mg/mL)

Blinatumomab

(Mfr: AMG)(Conc: 0.375 mcg/mL^b)

Remarks:

Persistent particulate formation when furosemide is added to blinatumomab; small flakes transiently appeared when order of mixing was reversed

Ref:

³⁴⁰⁵,³⁴¹⁷